N NOVO-NORDISK A S
| Market Cap | $164.13B |
| P/E Ratio | 10.39 |
| Forward P/E | 10.81 |
| Dividend Yield | 4.87% |
| Beta | 0.27 |
| 52W Range | $34.76 - $77.31 |
| # Hedge Funds | 3 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Hedge Fund Ownership
| Investor 3 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Thomas Gayner Markel Group | 1.16% | $146.01M | 2,869,774 | Add 21.16% |
| Sarah Ketterer Causeway Capital Management | 0.70% | $50.57M | 993,850 | Add 42.80% |
| Francois Rochon Giverny Capital | 0.02% | $630.00K | 12,400 | — |
Frequently Asked Questions
What is NVO stock price today?
NOVO-NORDISK A S (NVO) is currently trading at $36.98. The stock has a 52-week range of $34.76 to $77.31 and a market capitalization of $164.13B.
Is NVO a good stock to buy in 2026?
NOVO-NORDISK A S has a P/E ratio of 10.4 (forward P/E: 10.8), a dividend yield of 4.87%, and 1-year performance of -42.2%. 3 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling NVO stock?
There have been 0 insider transactions for NVO in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has NVO stock performed over the past year?
NOVO-NORDISK A S (NVO) has returned -42.2% over the past 12 months. The stock traded between $34.76 and $77.31 during this period, and is currently at $36.98.
Which hedge funds own NVO (NOVO-NORDISK A S)?
3 tracked hedge funds currently hold NVO in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is NVO's market cap and valuation?
NOVO-NORDISK A S (NVO) has a market capitalization of $164.13B. The trailing P/E ratio is 10.4 and forward P/E is 10.8. The stock is classified in the Healthcare sector.
What is NVO's revenue and profitability?
NOVO-NORDISK A S reported revenue of $309.06B with net income of $102.43B and a profit margin of 0.33%. The stock has a beta of 0.27.
What sector is NVO in and who are its biggest institutional holders?
NOVO-NORDISK A S (NVO) operates in the Healthcare sector. It is held by 3 tracked hedge funds. See the ownership table above for the complete list.